GENANI Trademark

Trademark Overview


On Thursday, April 30, 2020, a trademark application was filed for GENANI with the United States Patent and Trademark Office. The USPTO has given the GENANI trademark a serial number of 88894993. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, June 17, 2024. This trademark is owned by GENANI CORPORATION. The GENANI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations, namely, medications for the treatment of dermatological conditions
genani

General Information


Serial Number88894993
Word MarkGENANI
Filing DateThursday, April 30, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Description of MarkThe mark consists of the word "GENANI" in stylized font inside a horizontal oval egg design with the left side of the oval consisting of a DNA helix design.
Goods and ServicesPharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations, namely, medications for the treatment of dermatological conditions
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENANI CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Party NameGENANI CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Trademark Events


Event DateEvent Description
Monday, May 4, 2020NEW APPLICATION ENTERED
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 13, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 27, 2020ASSIGNED TO EXAMINER
Monday, August 3, 2020NON-FINAL ACTION WRITTEN
Monday, August 3, 2020NON-FINAL ACTION E-MAILED
Monday, August 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 22, 2021SUSPENSION LETTER WRITTEN
Monday, February 22, 2021LETTER OF SUSPENSION E-MAILED
Monday, February 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 20, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 28, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022SOU EXTENSION 1 FILED
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 23, 2022ASSIGNED TO EXAMINER
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2023SOU EXTENSION 2 FILED
Friday, June 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED
Monday, June 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU EXTENSION 4 FILED
Monday, June 17, 2024SOU EXTENSION 4 GRANTED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED